Within-Trial Cost-Effectiveness of a Structured Lifestyle Intervention in Adults With Overweight/Obesity and Type 2 Diabetes: Results From the Action for Health in Diabetes (Look AHEAD) Study.
Xilin ZhouKaren M AtkinsonGeorge A BrayHaiying ChenJeanne M ClarkMace CodayGareth R DuttonCaitlin EganMark A EspelandMary EvansJohn P ForeytFrank L GreenwayEdward W GreggHelen P HazudaJames O HillEdward S HortonEdward S HortonPeter J HuckfeldtSharon D JacksonJohn M JakicicRobert W JefferyKaren C JohnsonSteven E KahnTina KilleanWilliam C KnowlerWilliam C KnowlerCora E LewisNisa M MaruthurSara MichaelsMaria G MontezDavid M NathanJennifer PatricioAnne PetersAnne L PetersHenry PownallBruce RedmonJulia T RushingHelmut SteinburgThomas A WaddenRena R WingHolly WyattSusan Z Yanovskinull nullPublished in: Diabetes care (2020)
Whether ILI was cost-effective over the 9-year period is unclear because different health utility measures led to different conclusions.
Keyphrases
- type diabetes
- weight loss
- cardiovascular disease
- healthcare
- public health
- glycemic control
- metabolic syndrome
- insulin resistance
- mental health
- randomized controlled trial
- physical activity
- weight gain
- health information
- clinical trial
- study protocol
- body mass index
- human health
- high fat diet induced
- skeletal muscle
- light emitting